Inactive Instrument

Press Releases Covance Inc.

Equities

US2228161004

End-of-day quote Nyse Other stock markets
- ^USD	-

2014	Covance : Dow, S&P 500 close slightly lower; semis boost Nasdaq	RE
2014	Covance : LabCorp to pay $6.1 billion for drug trial company Covance	RE

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Covance : LabCorp Completes Acquisition of Covance	20/03/15	PU
Covance : Launches New Solution to Bridge Preclinical to Clinical Development	20/01/15	PR
Covance : Life Sciences Tools and Services Equities Coverage - Agilent Technologies, Thermo Fisher Scientific, Bruker, Quintiles Transnational, and Covance	08/12/14	PR
Covance : Stockholders Encouraged to Contact Securities Law Firm about Takeover	04/11/14	PR
Covance : Ryan & Maniskas, LLP : Announces Investigation of Covance Inc.	04/11/14	PR
Covance : LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World’s Leading Healthcare Diagnostics Company	03/11/14	BU
Covance : Technical Coverage on Life Sciences Tools and Services Equities - Agilent Technologies, Thermo Fisher Scientific, Pacific Biosciences of California, Sequenom, and Covance	27/10/14	PR
Covance : Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award	17/10/14	PR
Covance : Invites You to Join the Webcast of Its Third Quarter 2014 Financial Results Conference Call	08/10/14	PR
Covance : and Frenova Renal Research Establish	18/09/14	PU
Covance : To Present At The Morgan Stanley Global Healthcare Conference	07/09/14	PR
Covance : Financial Results, Investor Meeting Schedule, Dividend Declaration, and Technical Updates - Research Reports on Quest, Abaxis, Charles River Laboratories, PerkinElmer and Covance	30/07/14	PR
Covance : Invites You to Join the Webcast of Its Second Quarter 2014 Financial Results Conference Call	30/07/14	PR
Covance : Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million	29/07/14	PR
Covance : Increases its Medical and Scientific Leadership with Two Senior-Level Appointments	09/07/14	PU
Covance : C O R R E C T I O N -- Covance Inc./	02/07/14	PU
Covance : New Laws, Pricing of Offering, Recognitions, Donations, and Upcoming Conference Calls - Analyst Notes on Hospira, Prothena, Quintiles, Sirona and Covance	30/06/14	PR
Covance : C O R R E C T I O N -- Covance Inc./	25/06/14	PR
Covance : MarketPlace, a New Solution to Expedite Biopharmaceutical Development	24/06/14	PU
Covance : To Present At The William Blair 34th Annual Growth Stock Conference	09/06/14	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Covance Inc.

Equities

US2228161004

Press Releases

Filters